FDX1 suppresses acute myeloid leukemia progression and reverses cuproptosis resistance via the ROS/p53/ME1 axis
Summary Cuproptosis, a copper-dependent cell death mechanism, holds therapeutic potential in cancer, yet its regulatory pathways in acute myeloid leukemia (AML) remain poorly defined. We demonstrate that elevated serum copper levels correlate with poor prognosis in AML patients. Screening reveals that ferredoxin 1 (FDX...